QMCG Home

Issue 6, Vol. 2
August 2005


Partners in
Healthcare
Improvement


Charlene Nutter
Senior Consultant
(614) 227-4852
cnutt@qmcg.com

The Quality Management
Consulting Group, Ltd.
100 S. Third St.
Columbus, OH 43215
Ph: (614) 227-4848
Fx: (614) 227-2390
Email: info@qmcg.com

 

PROPOSED 2006 OPPS RULE PUBLISHED

In the July 25, 2005 Federal Register the proposed rules for the Medicare OPPS was published. Comments regarding the rule must be submitted to CMS by September 16, 2005.

The payment rates for 2006 are based on the median charges from the 2004 claims data. In this proposed rule, the beneficiary’s share of the outpatient bill is estimated to be 30% in 2006, down from 32% in 2005.

This newsletter will publish just a few significant highlights:

  • Observation Services
    These changes are being proposed:
  1. Discontinue HCPCS codes G0244 (observation care), G0263 (direct admission with CHF, chest pain or asthma) and G0264 (assessment other than CHF, chest pain or asthma) and create 2 new HCPCS codes to be used by hospitals to report all observation services whether separately payable or packaged.

    GXXXX – Hospital observation services, per hour
    GYYYY – Direct admission of patient for hospital observation care
     
  2. Shift the determination of whether the observation services are separately payable under APC 339 from the hospital to OPPS claims processing logic.
  • Multiple Diagnostic Imaging Procedures
    Currently hospitals billing for diagnostic procedures receive full APC payments for each imaging service on the claim regardless of how many procedures of the body are studied in the same session. CMS has identified 11 families of imaging procedures by modality (i.e., ultrasound, CT, CTA, MRI, MRA, etc.). It is proposed that CMS pay a 50% reduction in OPPS payment for some second and subsequent imaging procedures performed in the same session. The imaging procedure reduction is proposed only to individual services described in 1 family, not across families. These procedures within 1 family must be performed in the same session.
     
  • Payment for Procedures with Modifiers -52, -73, -74
    Each of these modifiers indicates that a procedure was terminated before completion. Currently, hospitals are paid 50% of the APC payment for a procedure with modifier -73 and 100% of the APC payment for procedures with modifier -52 and -74.

CMS is proposing to pay 50% of the APC payment for a discontinued procedure that does not require anesthesia, where modifier -52 is reported.

CMS is also proposing to pay 50% of the APC payment for a procedure when modifier -74 (procedure discontinued after anesthesia is initiated) is reported. However, CMS is seeking comment on the clinical circumstances in which modifier -74 would be used to assist in their evaluation of this payment reduction. In particular CMS is interested in obtaining information about “when” during the procedure the decision to discontinue is made. 

DME ORDERED IN THE HOSPITAL

CMS issued MedLearn Matters SE0507 on February 2, 2005. The article states that when an orthotic/prosthetic is medically necessary for a Medicare patient, ordered while the patient is still in the hospital but not delivered to the patient until the beneficiary has been discharged, the hospital (facility where the medical need occurred) is still responsible for the billing of the device.

HIPAA COMPLIANCE

According to CMS MedLearn Matters MM3956, effective October 1, 2005 CMS is ending its contingency plan that has allowed providers to submit claims format electronically that were not in the format required by HIPAA. All providers must use the HIPAA compliant format for claims submitted to Medicare. It is estimated that over 99% of claims submitted are already in HIPAA compliant formats.

NOTICE OF COMPUTER MATCHING PROGRAM (CMP) IN OHIO

On July 25, 2005 in the Federal Register it was noted that CMS filed a report of the CMP with the Chair of the House Committee on Government Reform and Oversight as well as other government offices. The purpose of the agreement will be to establish conditions, safeguards and procedures under which CMS will conduct a computer matching program with ODJFS to study claims, billings and eligibility information to detect suspected instances of fraud and abuse in the State of Ohio. 

Utilizing fraud detection software, the information will be used to identify aberrant practices that may constitute fraud and abuse. The following are examples of types of aberrant practices that may constitute fraud and abuse and are expected to be identified in this matching program: billing for provisions of more than 24 hours of services in 1 day, providing services and treatment in ways more statistically significant than similar practice groups, and upcoding and billing for services more expensive than those actually performed.

The CMP will be effective no sooner than 40 days after the report of the Matching Program is sent to Congress or 30 days after publication in the Federal Register, whichever is later. The matching program will continue for 18 months from the effective date. It could be extended another 12 months.

JULY 2005 UPDATE FOR OPPS

The following drugs and biologicals have been designated as eligible for pass-through status under the OPPS effective July 1, 2005.

HCPCS APC SI Long Description
C9127 9127 G Injection, Paclitaxel Protein Bound Particles, per 1 mg
C9128  9128  Injection, Pegaptiamib Sodium, per 0.3 mg
C9129  9129  G Injection, Clofarabine, per 1 mg
J8501* 0868  G Aprepitant, oral, 5 mg

*J8501 was approved for pass-through status effective April 6, 2005.

There are occasions when a hospital may furnish a device for surgical insertion for which the hospital incurs no cost (i.e., devices replaced under warranty, devices replaced due to recall, devices provided in a clinical trial or devices provided as a sample). Under OPPS hospitals must report a code for a device when reporting the procedure code for inserting the device or an edit will not allow the claim to be processed for payment. In those instances:

  • Hospitals paid under the OPPS that surgically implant a device furnished at no cost to the hospital shall report the appropriate HCPCS code for the device on type of bill 13x.

  • Hospitals paid under the OPPS that surgically implant a device furnished at no cost to the hospital shall report a charge of zero for the device, or if the hospital’s billing system requires that a charge be entered, the hospital shall submit a token charge (e.g., $1.00) on the line with the device code.

CMS recognizes that showing a charge for a device that has been furnished without cost is not optimal, but showing a token charge in this circumstance will allow claims for reasonable and necessary services that might otherwise be denied due to OCE edits to be paid, and will ensure that beneficiaries receive the care they need.

CHANGE REQUEST 3871, JULY 2005 OPPS SPECIFICATIONS

According to this Change Request, the following CPT/HCPCS codes have been deleted as blood products effective July 1, 2005:

86890  Autologous blood processing
P9041  Albumin (human), %5, 50 ml
P9045  Albumin (human), 5%, 250 ml
P9046  Albumin (human), 5%, 20 ml

Further clarification with AdminaStar Federal indicated these codes should now be reported with revenue code 636.